Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma

Published:2019-02-18 Issue:1 Volume:38 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

He Yizi,Li Jiao,Ding Ning,Wang Xiaogan,Deng Lijuan,Xie Yan,Ying Zhitao,Liu Weiping,Ping Lingyan,Zhang Chen,Song Yuqin,Zhu Jun

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Capital Foundation of Medical Development

Beijing Municipal Administration of Hospitals' Ascent Plan

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Beijing Municipal Administration of Hospitals Incubating Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-019-1076-4.pdf

Reference44 articles.

1. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.

2. Wilson WH, Young RM, Schmitz R, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015;21:922–6.

3. Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12–23.

4. Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013;12:229–43.

5. Duhren-von Minden M, Ubelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489:309–12.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor Effects and the Potential Mechanism of 10-HDA against SU-DHL-2 Cells;Pharmaceuticals;2024-08-20

2. Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells;Bioorganic & Medicinal Chemistry;2024-04

3. NF-κB in biology and targeted therapy: new insights and translational implications;Signal Transduction and Targeted Therapy;2024-03-04

4. Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives;Environmental Toxicology and Pharmacology;2023-09

5. Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy;Nano Today;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3